ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

In this ANZUP conference highlight, Andrew Weickhardt chats with Betsy Plimack, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Centre in the US. She talks about the future potential role of genetic mutations in urothelial cancer: can they predict response to treatments or even decide which treatments you should use? They also discuss the use of the new immuno-oncology agents in metastatic kidney cancer: what are the second line options, and how do we measure success of treatments- keep a close ear out for the emerging concept of treatment free survival as the yard stick for the immune-oncology agents.

You can listen to ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca online on Radio and Podcast. Open the player on this page to stream the available audio.

ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca is an episode from Talking Urology by Talking Urology.

This episode is 00:10:07 long.

This episode was published on Sep 25, 2019.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Talking Urology when more episodes are available from the podcast feed.